In patients with hormone receptor (HR)-positive, locally advanced or metastatic breast cancer, treatment with fulvestrant (Faslodex) demonstrated superiority over anastrozole (Arimidex) in achieving extended progression-free survival, according to a recent press release from AstraZeneca.
For protection against breast cancer recurrence, results from one recently reported study can best be described as “good news, bad news.”
Oncology nurses are portrayed as the compassionate, dedicated heroes they truly are in a short documentary-style film, Heroic Hearts: To Be an Oncology Nurse, the Movie, which premiered at the Oncology Nursing Society 41st Annual Congress.
A review of the incidence and management of hypersensitivity reactions to oxaliplatin revealed that many patients are unnecessarily taken off this important drug. Most reactions are mild, and most patients can be successfully rechallenged with the drug, according to a study presented at the 2016 Gastrointestinal Cancers Symposium by Kelly Markey, PharmD, of Moffitt Cancer Center, Tampa, FL.
To sign up for our newsletter or print publications, please enter your contact information below.
